[go: up one dir, main page]

WO1999048505A1 - Composition pharmaceutique a base de mineraux - Google Patents

Composition pharmaceutique a base de mineraux Download PDF

Info

Publication number
WO1999048505A1
WO1999048505A1 PCT/ES1998/000076 ES9800076W WO9948505A1 WO 1999048505 A1 WO1999048505 A1 WO 1999048505A1 ES 9800076 W ES9800076 W ES 9800076W WO 9948505 A1 WO9948505 A1 WO 9948505A1
Authority
WO
WIPO (PCT)
Prior art keywords
ppm
minerals
dermatological
cosmetic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES1998/000076
Other languages
English (en)
Spanish (es)
Inventor
Pedro Fernandez De Haro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/ES1998/000076 priority Critical patent/WO1999048505A1/fr
Publication of WO1999048505A1 publication Critical patent/WO1999048505A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof

Definitions

  • the technical sector to which the invention relates is the chemical, pharmacological and cosmetic. It is a therapeutic and pharmacological composition formed by a combination of minerals that acts as a therapeutic, cosmetic and sanitary agent, for the treatment of pathologies such as carcinomas, HIV and other immunological problems, also verifying important cosmetic and dermatological healing effects.
  • carcinomas and HIV are carried out through methods, to a greater or lesser extent, physically painful, with an unattractive presentation for the patient.
  • This invention also brings a novelty for its simplicity to carry it out and its absence of harmfulness to the patient.
  • a mixture of the following components is carried out, in the proportions that are set: GOLD, (0.02 PPM), SILICA, (30.40%), ALUMINA, (13.03%), TITANIUM (0.98%), CALCIUM, (28.08%), MAGNESIUM (6.4%), POTASSIC (1.06%), MANGANESE (1.07%), IRON, (3.4%), SILVER (15 PPM), ZINC, (155 PPM), COPPER (0.061%), COBALT (0.013%), NICKEL (0.016%) AND CARBONIC (9.45%) allowing to rest and then micronizing to obtain a greater fineness of dust Low density gray, in which the preparation is in a form suitable for oral administration by means of capsules.
  • the powder obtained through the described procedure an adequate amount of gelatin will be incorporated so that it takes the form of a cream and can be properly administered on the skin covering the affected area until completely absorbed.
  • the production must be carried out from the lands that have the combination of specified minerals and their industrial development, once the product is approved, it does not offer more difficulty than any cosmetic or pharmacological product.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se prête à une utilisation dans le secteur chimique, pharmaceutique et cosmétique et vise à combiner des produits totalement naturels dont le traitement possède des propriétés immunologiques, oncologiques, dermatologiques et cosmétiques. La formule ou description de l'invention résulte du mélange des composants suivants dans les proportions déterminées: or (0,02 ppm), silice (30,40 %), alumine (13,03 %), titane (0,98 %), calcium (28,08 %), magnésium (6,4 %), potassium (1,06 %), manganèse (1,07 %), fer (3,4 %), argent (15 ppm), zinc (155 ppm), cuivre (0,061 %), cobalt (0,013 %), nickel (0,016 %) et carbone (9,45 %).
PCT/ES1998/000076 1998-03-26 1998-03-26 Composition pharmaceutique a base de mineraux Ceased WO1999048505A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/ES1998/000076 WO1999048505A1 (fr) 1998-03-26 1998-03-26 Composition pharmaceutique a base de mineraux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES1998/000076 WO1999048505A1 (fr) 1998-03-26 1998-03-26 Composition pharmaceutique a base de mineraux

Publications (1)

Publication Number Publication Date
WO1999048505A1 true WO1999048505A1 (fr) 1999-09-30

Family

ID=8302424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES1998/000076 Ceased WO1999048505A1 (fr) 1998-03-26 1998-03-26 Composition pharmaceutique a base de mineraux

Country Status (1)

Country Link
WO (1) WO1999048505A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2890857A1 (fr) * 2005-09-22 2007-03-23 Bulgari Parfums Sa Composition a base de concentres mineraux derives de pierres precieuses.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401445A1 (fr) * 1989-05-31 1990-12-12 Alix-Roland Commin Préparation aqueuse à base de sels minéraux et d'acide acétique pour la prévention et le traitement des maladies virales
US5069912A (en) * 1985-02-19 1991-12-03 Jensen Charles A Method of treating spastic colitis
CH684630A5 (fr) * 1992-08-21 1994-11-15 Danielle Girardet Composition pharmaceutique à base d'oligo-éléments.
EP0631785A1 (fr) * 1993-07-01 1995-01-04 Hatutio Co., Ltd Solution minérale ionienne, agent contre le virus humain d'immuno-déficience et agent pour le traitement du SIDA

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069912A (en) * 1985-02-19 1991-12-03 Jensen Charles A Method of treating spastic colitis
EP0401445A1 (fr) * 1989-05-31 1990-12-12 Alix-Roland Commin Préparation aqueuse à base de sels minéraux et d'acide acétique pour la prévention et le traitement des maladies virales
CH684630A5 (fr) * 1992-08-21 1994-11-15 Danielle Girardet Composition pharmaceutique à base d'oligo-éléments.
EP0631785A1 (fr) * 1993-07-01 1995-01-04 Hatutio Co., Ltd Solution minérale ionienne, agent contre le virus humain d'immuno-déficience et agent pour le traitement du SIDA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 1994-349923 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2890857A1 (fr) * 2005-09-22 2007-03-23 Bulgari Parfums Sa Composition a base de concentres mineraux derives de pierres precieuses.
WO2007034088A3 (fr) * 2005-09-22 2007-06-14 Bulgari Parfums Sa Composition a base de concentres mineraux derives de pierres precieuses

Similar Documents

Publication Publication Date Title
EP1602371A3 (fr) Acide valproique et ses dérivés pour la sensibilisation de cellules humaines pour augmenter l'efficacité dans une thérapie combinée
BR0115162A (pt) Tratamentos antitumorais eficazes
RU2007145489A (ru) Фармацевтические композиции и способы лечения рака и его метастазов
Chen et al. Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
CA2692234C (fr) Utilisation de dexanabinol pour le traitement de melanome
ECSP088348A (es) Composiciones de suplemento de hierro con tolerancia mejorada
CA2449856A1 (fr) Compositions pharmaceutique et de diagnostic contenant des nanoparticules utiles pour le traitement de tissus et de cellules cibles
WO2018039755A1 (fr) Formulation pharmaceutique à base de zinc et de quercétine pour la production d'un médicament antiviral efficace contre la dengue et zika
ES2733938T3 (es) Aditivo alimentario biológicamente activo para normalizar la función de la glándula tiroides
PE20031047A1 (es) Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
CN116726021A (zh) 一种drp1抑制剂和铁死亡诱导剂联合用药物及其抗肿瘤的用途
WO1999048505A1 (fr) Composition pharmaceutique a base de mineraux
EA007685B1 (ru) Фармацевтическая композиция, содержащая толуолсульфонамид, и способы ее получения и применения
ES2215307T3 (es) Composiciones con accion sinergica para combatir selectivamente tejidos tumorales.
GB2356347B (en) Pharmaceutical compositions and their use
Liau et al. Winning formulas to fulfill cancer moonshot
SE9901572D0 (sv) New compounds
CN103405398A (zh) 一种尿囊素制剂及其用途
US20060240119A1 (en) Pharmacologically active strong acid solutions
CN104146999B (zh) 冬凌草甲素和多烯紫杉醇减毒增效抗肿瘤药物组合物及其应用
DE3823735A1 (de) Verwendung von d-leucin (rechtsdrehende (alpha)-amino-isocapronsaeure) als wirkstoff zur bekaempfung maligner tumoren des schleimhautepithels des gesamten intestinaltraktes einschliesslich pankreas und gallenblase
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
ZA200600165B (en) Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase